Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 4.24 Billion | USD 30.75 Billion | 24.6% | 2024 |
FrequentlyAsked Questions
The global crispr genome editing market is expected to grow due to increasing research and development in gene therapy, drug discovery, and agricultural biotechnology, coupled with the technology's precision, efficiency, and expanding applications.
According to a study, the global crispr genome editing market size was worth around USD 4.24 Billion in 2024 and is expected to reach USD 30.75 Billion by 2034.
The global crispr genome editing market is expected to grow at a CAGR of 24.6% during the forecast period.
North America is expected to dominate the crispr genome editing market over the forecast period.
Leading players in the global crispr genome editing market include Thermo Fisher Scientific, Merck KGaA, GenScript, Sangamo Therapeutics, Lonza, CRISPR Therapeutics AG, Precision Biosciences.,, among others.
The report explores crucial aspects of the crispr genome editing market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed